Leukemia, Myeloid, Acute
Showing 1 - 25 of >10,000
Leukemia, Myeloid, Acute Trial in Baltimore (Flotetuzumab)
Not yet recruiting
- Leukemia, Myeloid, Acute
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Aug 16, 2022
Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Venetoclax)
Not yet recruiting
- Leukemia, Myeloid, Acute
-
Guanzhou, Guandong, ChinaNanfang Hospital of Southern Medical University
Jul 22, 2022
Leukemia, Myeloid, Acute Trial in Chengdu (Chidamide)
Recruiting
- Leukemia, Myeloid, Acute
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Dec 27, 2022
Acute Myeloid Leukemia Patients on Correlation to CD200 and CD56
Not yet recruiting
- Acute Myeloid Leukemia
- bone marrow aspirate and biopsy
- (no location specified)
Aug 20, 2022
Novel Digital Array PCR for Acute Myeloid Leukemia (AML)
Recruiting
- Leukemia, Myeloid, Acute
- Minimal Residual Disease
-
Chapel Hill, North CarolinaNorth Carolina Cancer Hospital (NCCH)
Jun 10, 2022
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti-siglec-6 CAR-T cell therapy)
Recruiting
- Acute Myeloid Leukemia Refractory
- Acute Myeloid Leukemia, in Relapse
- anti-siglec-6 CAR-T cell therapy
-
Xuzhou, Jiangsu, ChinaKailin Xu
Aug 2, 2022
Acute Myeloid Leukemia Trial in Cincinnati (CIML-NK Cells)
Recruiting
- Acute Myeloid Leukemia
- CIML-NK Cells
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jan 4, 2023
Relapsed/Refractory Acute Myeloid Leukemia Trial in Hangzhou (B7-H3 target, CAR gene modified gdT cell injection)
Recruiting
- Relapsed/Refractory Acute Myeloid Leukemia
- B7-H3 target, CAR gene modified gdT cell injection
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of Med
Feb 15, 2023
Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Miami (Bomedemstat,
Recruiting
- Acute Myeloid Leukemia
- +2 more
-
Miami, FloridaUniversity of Miami
Dec 22, 2022
Acute Myeloid Leukemia Trial in Beijing (azacytidine;cytarabine;aclamycin;Chidamide;venetoclax;granulocyte)
Recruiting
- Acute Myeloid Leukemia
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Dec 13, 2022
Acute Myeloid Leukemia Trial in Houston (SNDX-5613)
Not yet recruiting
- Acute Myeloid Leukemia
-
Houston, TexasMD Anderson Cancer Center
Jul 27, 2022
Relapsed/Refractory Acute Myeloid Leukemia Trial (LILRB4 STAR-T cells)
Not yet recruiting
- Relapsed/Refractory Acute Myeloid Leukemia
- LILRB4 STAR-T cells
- (no location specified)
Sep 16, 2022
AML, Acute Myeloid Leukemia Trial in Boston (DREAMLAND, CERENA)
Not yet recruiting
- AML
- Acute Myeloid Leukemia
- DREAMLAND
- CERENA
-
Boston, MassachusettsMassachusetts General Hospital
Aug 12, 2022
Leukemia, Myeloid, Acute Trial in Poznan (Liposomal Annamycin, Cytarabine)
Not yet recruiting
- Leukemia, Myeloid, Acute
- Liposomal Annamycin
- Cytarabine
-
Poznań, PolandSzpital Kliniczny Przemienienia Pańskiego Uniwersytetu Medyczneg
Jun 30, 2022
Analyze Occurrence of Transformation From Myelodysplastic
Completed
- Myelodysplastic Syndromes
- Leukemia, Myeloid, Acute
-
Kobe, Hyogo, JapanShinko Hospital
Jun 13, 2022
Acute Myeloid Leukemia (AML) Trial in Charlotte (Allogeneic HCT, Consolidation chemo)
Terminated
- Acute Myeloid Leukemia (AML)
- Allogeneic HCT
- Consolidation chemotherapy
-
Charlotte, North CarolinaLevine Cancer Institute
Apr 19, 2022
Mold Infections in Children During Leukemia Treatment
Not yet recruiting
- Leukemia, Myeloid, Acute
- Acute Lymphoblastic Leukemia
-
Odense, DenmarkRasmus Møller Duus
Mar 7, 2023
Relapsed or Refractory Acute Myeloid Leukemia (AML) Trial (Mitoxantrone Hydrochloride Liposome)
Not yet recruiting
- Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Mitoxantrone Hydrochloride Liposome
- (no location specified)
Apr 19, 2022
Healthcare Resource Utilization in Adults Diagnosed With Acute
Completed
- Acute Myeloid Leukemia (AML)
-
Helsinki, FinlandNovartis Investigative Site
Aug 3, 2022
Acute Myeloid Leukemia Trial (with or without venetoclax)
Not yet recruiting
- Acute Myeloid Leukemia
- with or without venetoclax
- (no location specified)
Apr 29, 2022
Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)
Recruiting
- Relapsed or Refractory Acute Myeloid Leukemia
- Selinexor
- +5 more
-
Taiyuan, Shanxi, ChinaTao Wang
Feb 9, 2023
Acute Myeloid Leukemia Trial in Xi'an (infusion of natural killer cells)
Recruiting
- Acute Myeloid Leukemia
- infusion of natural killer cells
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Apr 17, 2022
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia Recurrent Trial in Beijing (CD123-CAR-NK cells)
Recruiting
- Acute Myeloid Leukemia Refractory
- Acute Myeloid Leukemia Recurrent
- CD123-CAR-NK cells
-
Beijing, Beijing, ChinaThe Fifth Medical Center of Chinese People's Liberation Army (PL
Oct 24, 2022
Relapsed/Refractory Acute Myeloid Leukemia Trial in Hefei (gdT cell injection targeting B7-H3 chimeric antigen receptor)
Recruiting
- Relapsed/Refractory Acute Myeloid Leukemia
- gdT cell injection targeting B7-H3 chimeric antigen receptor
-
Hefei, Anhui, ChinaPersonGen Anke Cellular Therapeutice Co., Ltd.
Jan 31, 2023